Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Bile Duct Carcinoma”

284 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 284 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151872
What this trial is testing

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

Who this might be right for
CLDN18.2-positive Advanced Biliary Tract Cancer
Qilu Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)UnknownNCT05822453
What this trial is testing

Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Peking Union Medical College Hospital 20
Not applicableStudy completedNCT04478175
What this trial is testing

Prospective Evaluation of a Program for Early Identification of Needs and Multidisciplinary Intervention in Supportive Care in Digestive Oncology

Who this might be right for
Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma)Colorectal With Associated Risk Factors
Institut Curie 30
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)Ended earlyNCT05009953
What this trial is testing

Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+1 more
CSPC Ouyi Pharmaceutical Co., Ltd. 17
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Study completedNCT03531320
What this trial is testing

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

Who this might be right for
Gastrointestinal CancerBiliary Tract Cancer
InnoPharmax Inc. 19
Early research (Phase 1)Study completedNCT03358849
What this trial is testing

Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Yonsei University 9
Testing effectiveness (Phase 2)Study completedNCT00003276
What this trial is testing

Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer

Who this might be right for
Gallbladder Cancer
Alliance for Clinical Trials in Oncology 40
Testing effectiveness (Phase 2)Looking for participantsNCT07433673
What this trial is testing

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Who this might be right for
Colon and Rectal Cancer
Columbia University 20
Early research (Phase 1)Looking for participantsNCT06546969
What this trial is testing

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinoma
University of Maryland, Baltimore 15
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05820906
What this trial is testing

Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04298021
What this trial is testing

DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

Who this might be right for
Bile Duct CancerChemotherapy Effect
Seoul National University Hospital 74
Testing effectiveness (Phase 2)Study completedNCT01284413
What this trial is testing

Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group 68
Testing effectiveness (Phase 2)UnknownNCT05509478
What this trial is testing

Lenvatinib Combined With PD-1 Inhibitors as First-line Treatment for Unresectable/Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Cancer
The First Hospital of Jilin University 46
Not applicableNot Yet RecruitingNCT07830628
What this trial is testing

Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
CHA University 100
Next Page